Related Experiment Video
Updated: Sep 1, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
Palliative care in pediatric patients with central nervous system cancer: Descriptive and comparative study
Iñigo de Noriega1, Ricardo Martino Alba1, Blanca Herrero Velasco2
1Pediatric Palliative Care Unit, Hospital Infantil Universitario del Niño Jesús, Madrid, Spain.
Insights
Pediatric palliative care (PPC) for children with central nervous system (CNS) cancer addresses medical, social, and psychological needs. PPC improves end-of-life care by reducing hospital stays and increasing home deaths.
Area of Science:
- Pediatric Oncology
- Palliative Care
- Neuro-oncology
Background:
- Palliative needs of pediatric patients with central nervous system (CNS) cancer are under-researched.
- Pediatric palliative care (PPC) teams offer comprehensive support for complex conditions.
Purpose of the Study:
- To describe PPC interventions for pediatric CNS cancer patients.
- To compare end-of-life care for pediatric CNS cancer patients with and without PPC.
Main Methods:
- Retrospective study of deceased pediatric CNS cancer patients over 10 years.
- Analysis of medical, psychological, social, and nursing interventions provided by a PPC team.
- Comparison of last month of life care between patients who received PPC and those who did not.
Main Results:
- 59 of 71 patients received PPC, with a median of 1.6 months from referral to death.
- PPC involved home hospitalization (84.8%), nursing (89.8%), psychological (84.7%), and social (88.1%) interventions.
- PPC patients had fewer hospital days and higher rates of home death (50% vs. 0%) compared to non-PPC patients.
Conclusions:
- Pediatric CNS cancer patients have significant end-of-life medical, social, and psychological needs.
- PPC interventions are associated with reduced hospitalization and increased home deaths for pediatric CNS cancer patients.
Objectives:
Data regarding the palliative needs of pediatric patients with central nervous system (CNS) cancer are scarce. We aimed to describe the attention provided by a pediatric palliative care (PPC) team to patients with CNS cancer and the differences in care compared to patients who did not receive PPC.
Method:
This retrospective study was based on the clinical records of deceased patients with CNS cancer attended by a PPC team over 10 years, analyzing their trajectory and provision of PPC, including medical, psychological, social, and nursing interventions. Furthermore, we compared the last month of life care of deceased patients with CNS cancer in the same institution, based on whether they were attended by the PPC team.
Results:
Of 71 patients, 59 received PPC, with a median of 1.6 months (Interquartile range: 0.6-5.2) from referral to death. Home hospitalization was provided to 84.8%, nursing interventions were registered in 89.8%, psychological characteristics in 84.7%, and social interventions in 88.1%. The most common symptoms were pain, dyspnea, and constipation. When comparing patients from the same hospital who received PPC (n = 36) with those who did not (n = 12), the former spent fewer days in the hospital in their last month and last week (p < 0.01) and were more likely to die at home (50% vs. 0%; p < 0.01).
Significance Of Results:
Patients with CNS cancer show various medical, social, and psychological needs during end-of-life care. Providing specific PPC interventions decreased the number of days spent at the hospital and increased the rate of death at home.
Related Concept Videos
Continuing Care
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Targeted Cancer Therapies
There are several types of targeted therapies against...

